Three drug-like molecules selectively inhibit β-arrestins, providing new tools to study cell signaling and develop more precise medicines. To function normally, nearly every cell in the human body relies on G-protein coupled receptors (GPCRs) to receive and send signals. That’s why GPCRs are targeted by roughly one-third of all FDA‑approved drugs. But the signals from these receptors do... [3963 chars]
ADVERTISEMENT
ADVERTISEMENT
2026 Copyright © News-Matic.com. All Rights Reserved
